R
Rocket Pharmaceuticals, Inc. (RCKT)
NGM – Real Time Price. Currency in USD
3.64
+0.05 (1.39%)
At close: May 12, 2026, 4:00 PM EDT
3.57
-0.07 (-1.92%)
Pre-market: May 13, 2026, 4:10 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
3.64
+0.05 (1.39%)
At close: May 12, 2026, 4:00 PM EDT
3.57
-0.07 (-1.92%)
Pre-market: May 13, 2026, 4:10 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.12 | 6.05 | 10 | |
| Quick ratio | 6.12 | 5.63 | 10 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.09 | 1.04 | 9.0 | |
| Interest coverage | -102.56 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -6M | -7M | -9M | -11M | -10M |
| Operating Income | -224M | -260M | -273M | -229M | -213M |
| Net Income | -222M | -246M | -259M | -223M | -209M |
| EBITDA | -218M | -253M | -264M | -217M | -202M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 64.24 | 5.5 |
| Next quarter | N/A | 37.06 | 5.5 |
| Current year | N/A | 46.35 | 5.5 |
| Next year | 762.62 | -14.57 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -11.88 | -10.52 | -30.24 | 3.3 |
| Y/Y | 999 | 22.4 | 25 | 19.01 | 9.8 |
| 3y average | 999 | -0.74 | 14.44 | -1.13 | 5.0 |
| 5y average | 999 | -10.89 | 3.06 | -13.26 | 4.0 |
| Weighted average score | 5.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $49.6M significantly exceed its total debt $24.8M, ensuring strong financial flexibility
Total current assets $149.8M exceed Total current liabilities $24.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-102.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$45.5M limits the company's ability to reinvest or pay down debt